Affymetrix, Inc. (NASDAQ:AFFX)

CAPS Rating: 3 out of 5

Engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets and create tools that advances the understanding of the molecular basis of life.

Results 1 - 20 of 57 : 1 2 3 Next »

Recs

0
Member Avatar pchop123 (76.53) Submitted: 5/10/2013 12:39:30 PM : Outperform Start Price: $3.77 AFFX Score: -3.71

big rebound underway

Recs

1
Member Avatar zzlangerhans (99.78) Submitted: 7/10/2012 12:18:28 PM : Outperform Start Price: $4.43 AFFX Score: -38.81

I don't really remember how Affymetrix got into my data base. It's not a biopharma and I don't really know the first thing about equipment for genetic analysis. Maybe I got it mixed up with Affymax once. Regardless, I've been keeping an eye on their sales and their share price for a few years now and I've had some success on CAPS picks when one becomes discordant with the other.

Revenues have been stable the last few quarters but the cash burn was substantially lower in Q2. The share price was recently as high as 5.4 but has declining after the company announced a 109M debt financing. I'm not a big fan of debt, but I've seen many companies in this sector use it as an effective tool for growth. The share price could easily decline to recent lows of 4, but I believe that ultimately the stock will remain range-bound and I'll be able to close the pick over 5.

Recs

0
Member Avatar RBuskey106 (< 20) Submitted: 4/9/2012 1:54:37 PM : Outperform Start Price: $4.15 AFFX Score: -31.30

Chart Play

Recs

0
Member Avatar stainsolution (< 20) Submitted: 4/9/2012 1:26:34 PM : Outperform Start Price: $4.15 AFFX Score: -31.30

Chart Play

Recs

0
Member Avatar seyer (< 20) Submitted: 2/13/2012 1:46:02 PM : Outperform Start Price: $4.65 AFFX Score: -43.29

Affy chips are paving the way for personalized medicine.

Recs

0
Member Avatar KimLanners (< 20) Submitted: 7/7/2011 11:05:06 AM : Underperform Start Price: $6.49 AFFX Score: +66.24

this is going to 5$!

Recs

0
Member Avatar geo11zak (< 20) Submitted: 12/16/2010 8:14:47 AM : Outperform Start Price: $4.50 AFFX Score: -51.73

valuation, great potential

Recs

0
Member Avatar KR1527 (< 20) Submitted: 10/20/2010 2:10:34 PM : Outperform Start Price: $4.53 AFFX Score: -59.25

Deeply oversold and about to return to profitability so the stock should get above $6 in the next 3-12 months.

Recs

0
Member Avatar whomonkyoulus (28.80) Submitted: 10/13/2010 4:15:51 PM : Outperform Start Price: $4.52 AFFX Score: -59.38

Insider buys. Growth sector.
Cash flows do not show the grim picture than accounting does.

Recs

0
Member Avatar franktejon (< 20) Submitted: 7/7/2010 10:25:05 PM : Outperform Start Price: $4.14 AFFX Score: -66.14

strong buy

Recs

0
Member Avatar lytri (83.25) Submitted: 7/7/2010 1:49:38 PM : Outperform Start Price: $4.14 AFFX Score: -68.92

Knocked down quite badly today, but genetic testing is ramping up. As it becomes more common for companies to turn to this, AFFX will continue to grow.

Recs

0
Member Avatar elica (< 20) Submitted: 2/18/2010 10:58:45 AM : Outperform Start Price: $7.65 AFFX Score: -102.58

great tech signs

Recs

0
Member Avatar ipfmanager (88.45) Submitted: 11/16/2009 5:45:38 PM : Outperform Start Price: $5.20 AFFX Score: -78.98

nih grant

Recs

1
Member Avatar PatrickDickey (37.98) Submitted: 8/6/2009 1:29:20 AM : Outperform Start Price: $9.30 AFFX Score: -126.49

I'm counting on AFFX to innovate in the field of Genetic mapping, and bring their prices down to the same level or at least a more fitting level for their products. Plus, with the other Genetic Mapping companies in the game, I think they will all benefit in the next five years or so.

Recs

0
Member Avatar 108600 (< 20) Submitted: 8/2/2009 2:11:08 PM : Outperform Start Price: $9.04 AFFX Score: -126.91

semiconductor sector starting to turn up.

Recs

1
Member Avatar John789 (24.85) Submitted: 8/1/2008 6:41:29 PM : Outperform Start Price: $8.41 AFFX Score: -92.45

can't get any lower

Recs

0
Member Avatar biovestor (< 20) Submitted: 6/28/2008 4:00:08 PM : Outperform Start Price: $10.03 AFFX Score: -97.65

An out-of-favor provider of research tools and systems for genetic analysis that is poised to regain investor favor due to the need for innovation in biotech and pharma industry.

Recs

0
Member Avatar alex0144a (< 20) Submitted: 6/26/2008 12:06:53 PM : Outperform Start Price: $10.16 AFFX Score: -96.55

the stock has been beaten up and the chart is positive

Recs

0
Member Avatar itainvestor (96.35) Submitted: 5/27/2008 3:39:17 PM : Outperform Start Price: $11.85 AFFX Score: -93.31

Rule Breaker, Insiders, Sector bet

Recs

0
Member Avatar RRangarajan (32.39) Submitted: 5/21/2008 9:54:18 PM : Outperform Start Price: $12.06 AFFX Score: -90.47

potential to do well in future

Results 1 - 20 of 57 : 1 2 3 Next »

Featured Broker Partners


Advertisement